![]() |
(5S,8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5] diazocine-8-carboxyamide |
---|---|
Trade Name | |
Orphan Indication | Ovarian cancer |
USA Market Approval | USA |
USA Designation Date | 2016-04-14 00:00:00 |
Sponsor | DebioPharm International SA;Forum "apres-demain", Chemin Messidor, 5-7;Lausanne |